Dose Response Study Of Lasofoxifene In Postmenopausal Women With Osteoporosis (Placebo-Controlled, Multicenter, Double-Blind, Comparative Study) - Japanese Asian Dose Evaluation: JADE.

Trial Profile

Dose Response Study Of Lasofoxifene In Postmenopausal Women With Osteoporosis (Placebo-Controlled, Multicenter, Double-Blind, Comparative Study) - Japanese Asian Dose Evaluation: JADE.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Lasofoxifene (Primary)
  • Indications Menopause; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms JADE
  • Most Recent Events

    • 18 Jul 2011 Company added as trial sponsor as reported by ClinicalTrials.gov.
    • 23 Feb 2010 Official Title amended as reported by ClinicalTrials.gov.
    • 23 Feb 2010 Actual patient number (497) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top